UBS’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$267K Sell
3,300
-600
-15% -$50.1K ﹤0.01% 4885
2014
Q2
$341K Buy
3,900
+3,800
+3,800% +$330K ﹤0.01% 4603
2014
Q1
$9K Sell
100
-6,700
-99% -$549K ﹤0.01% 8994
2013
Q4
$549K Buy
6,800
+4,000
+143% +$311K ﹤0.01% 4221
2013
Q3
$218K Sell
2,800
-1,300
-32% -$100K ﹤0.01% 5070
2013
Q2
$287K Buy
+4,100
New +$286K ﹤0.01% 4699

Other funds holding EMN

UBS's EMN Position: Q3 2014 in Review

UBS increased its Eastman Chemical (EMN) stake by 18% in Q3 2014, buying an estimated $4.9M and bringing the position to 386,758 shares worth $31.3M. The position accounts for 0.02% of the portfolio, ranked #709.

UBS first reported a position in EMN in Q2 2013 and has held it in 6 quarters since. 533 funds tracked by Wall St. Rank hold EMN as of Q3 2014.

  • UBS held 386,758 shares of Eastman Chemical worth $31.3M as of Q3 2014.
  • UBS bought 58,681 Eastman Chemical shares in Q3 2014, an estimated $4.9M.
  • Eastman Chemical made up 0.02% of UBS's portfolio in Q3 2014, its #709 holding.
  • UBS first reported a position in Eastman Chemical in Q2 2013 and has held it in 6 quarters since.
  • 533 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.